PATENT MEDICINE VENDORS’ PREPAREDNESS AND RESPONSE FOR THE PREVENTION AND CONTROL OF COVID-19 INFECTION IN A NORTH-CENTRAL STATE IN NIGERIA

Objective: This report aimed to determine the immediate effect of the IPC training on the knowledge and role of patent medicine vendors (PMV) in the COVID-19 outbreak response in Nigeria. Methods: We conducted a quasi-experimental study before and after the IPC training among 1076 PMV in Ilorin, Kwara state, Nigeria. Data analysis was done using SPSS version 23. Eight questions were asked, for which each was assigned a score of “1”. Participants who had scored<50% were categorized as “Fail”, while those with scores ≥50% were categorized as “Pass” in both the pre and post-tests. The Chi-square test was used to test for the association between sociodemographic characteristics and performance of respondents in the pre-and post-IPC knowledge results, and paired t-test to test for significant differences between the pre and post-tests mean scores. The level of significance was set at p<0.05 for all statistical tests. Results: The mean age of the 1076 respondents was 37.06±10.96, 463(43%) passed the pre-test, while 617 (57.3%) passed the post-test. The mean pre-test IPC training score was 3.1310±1.5631, while the mean post-test IPC training score was 3.7351±1.6028 (t=-11.337, p=<0.001). In all, 617(57.3%) scored higher in posttest. Overall, 560 (92.41%) identified community sensitization and health education on COVID-19 preventive measures as roles of PMV. Conclusion: Regular trainings on COVID-19 preventive practices among PMV should be conducted. PMV should be empowered to sensitize and educate their clients on the prevention of COVID-19.

[1]  A. Afolabi,et al.  Six months of COVID-19 response in Nigeria: lessons, challenges, and way forward , 2020 .

[2]  A. Afolabi,et al.  Perception and practices during the COVID-19 pandemic in an urban community in Nigeria: a cross-sectional study , 2020, PeerJ.

[3]  O. Ilesanmi,et al.  In Search of the True Prevalence of COVID-19 in Africa: Time to Involve More Stakeholders , 2020, International Journal of Health and Life Sciences.

[4]  S. Wani,et al.  OUTBREAK, EPIDEMIOLOGY, THERAPEUTICS AND PREVENTION OF CORONAVIRUS DISEASE-2019: A REVIEW , 2020, International Journal of Current Pharmaceutical Research.

[5]  Abayomi J. Akande,et al.  Overcoming COVID-19 in West African countries: is herd immunity an option? , 2020, The Pan African medical journal.

[6]  M. José,et al.  CURRENT THERAPEUTIC OPTIONS FOR CORONAVIRUS DISEASE-2019 – A PHARMACOLOGICAL REVIEW , 2020, Asian Journal of Pharmaceutical and Clinical Research.

[7]  C. Fenenga,et al.  Operations and roles of patent and proprietary medicine vendors in selected rural communities in Edu Local Government Area, Kwara State, north-central Nigeria , 2018 .

[8]  O. Ajumobi,et al.  The role of drug vendors in improving basic health-care services in Nigeria , 2016, Bulletin of the World Health Organization.

[9]  Jenny X. Liu,et al.  Social support in the practices of informal providers: The case of patent and proprietary medicine vendors in Nigeria. , 2015, Social science & medicine.

[10]  Jenny Liu,et al.  Care-seeking at patent and proprietary medicine vendors in Nigeria , 2015, BMC Health Services Research.

[11]  Jenny X. Liu,et al.  Management of paediatric illnesses by patent and proprietary medicine vendors in Nigeria , 2015, Malaria Journal.

[12]  Jenny X. Liu,et al.  A Systematic Review of the Role of Proprietary and Patent Medicine Vendors in Healthcare Provision in Nigeria , 2015, PloS one.

[13]  S. Omale,et al.  Medicine Vendors: Self-medication Practices and Medicine Knowledge , 2012, North American journal of medical sciences.